IsoRay Inc (ISR):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:IsoRay Inc (ISR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7360
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a radioactive isotope used in brachytherapy for the treatment of prostate, brain, lung, head, neck and gynecological cancers. Brachytherapy involves placing the radiation sources – seeds – very close to the tumor site in order to destroy the cancer cells. Cesium 131 provides a specifically targeted, quick-acting radiation treatment. Its initial application is the treatment of localized prostate cancer. It serves medical centers, hospitals and clinics across the US. IsoRay is headquartered in Richland, Washington, the US.

IsoRay Inc (ISR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
IsoRay Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
IsoRay Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
IsoRay Inc, Medical Equipment, Deal Details 11
Equity Offering 11
IsoRay to Raise USD8.3 Million in Private Placement of Shares 11
IsoRay Completes Private Placement Of Shares For US$14.7 Million 13
IsoRay Amends Terms Of Public Offering Of Units For US$3.7 Million 14
IsoRay Inc – Key Competitors 15
IsoRay Inc – Key Employees 16
IsoRay Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
May 03, 2018: IsoRay Announces Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Third Quarter-Over-Third Quarter Increase 18
Apr 18, 2018: IsoRay Announces Preliminary Third Quarter Fiscal 2018 Financial Results 19
Jan 24, 2018: IsoRay Announces Preliminary Second Quarter F2018 Revenue of $1.54 Million, 50% Year-over-Year Increase 20
Nov 14, 2017: IsoRay Announces First Quarter Fiscal 2018 Financial Results 21
Aug 04, 2017: IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of $1.37 Million, 22% Year-over-Year Increase 22
May 10, 2017: IsoRay Announces Third Quarter Fiscal 2017 Financial Results 23
Feb 08, 2017: IsoRay Announces Second Quarter Fiscal 2017 Financial Results 25
Corporate Communications 27
Jun 19, 2018: IsoRay Announces Entry into Employment Agreement with Lori A. Woods as Interim CEO 27
Jun 05, 2018: IsoRay Announces Senior Management Change 28
Jul 07, 2017: Isoray announces appointment of mark austin as controller, principal accounting and financial officer 29
Legal and Regulatory 30
Mar 09, 2017: IsoRay Announces Final Court Approval of Class Action Settlement 30
Government and Public Interest 31
Sep 12, 2018: IsoRay: Three recent peer-reviewed publications reinforce the value of brachytherapy as a treatment for prostate cancer 31
Product News 32
Mar 21, 2018: New study reports that combination treatment with brachytherapy yields significantly better outcomes for men with aggressive prostate cancer 32
Sep 26, 2017: IsoRay Announces Study Accepted for Publication in the International Journal of Radiation Oncology, Biology, Physics entitled “Re-irradiation using Permanent Interstitial Brachytherapy 33
Sep 25, 2017: IsoRay Announces “Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial” Poster Presentation at 2017 Annual American Society for Radiation Oncology Conference 34
May 03, 2017: IsoRay Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics entitled “Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131” 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
IsoRay Inc, Medical Equipment, Key Facts, 2017 2
IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
IsoRay Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
IsoRay Inc, Deals By Market, 2012 to YTD 2018 9
IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
IsoRay to Raise USD8.3 Million in Private Placement of Shares 11
IsoRay Completes Private Placement Of Shares For US$14.7 Million 13
IsoRay Amends Terms Of Public Offering Of Units For US$3.7 Million 14
IsoRay Inc, Key Competitors 15
IsoRay Inc, Key Employees 16
IsoRay Inc, Subsidiaries 17

List of Figures
IsoRay Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
IsoRay Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
IsoRay Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
IsoRay Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[IsoRay Inc (ISR):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Balkrishna Industries Ltd:企業の戦略・SWOT・財務情報
    Balkrishna Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Balkrishna Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • SUPERVALU INC.:戦略・SWOT・企業財務分析
    SUPERVALU INC. - Strategy, SWOT and Corporate Finance Report Summary SUPERVALU INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Inner Mongolia Yili Industrial Group Co Ltd:企業の戦略・SWOT・財務情報
    Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Acceleron Pharma Inc (XLRN)-製薬・医療分野:企業M&A・提携分析
    Summary Acceleron Pharma Inc (AcceleronPharma) is a clinical stage biopharmaceutical company that discovers, developsand commercializes therapeuticsto treat serious and rare diseases. The company’s lead therapeutic candidate, luspatercept, is in phase 3 studyused for the treatment of the myelodyspla …
  • ShanPar Industries Pvt. Ltd.:戦略・SWOT・企業財務分析
    ShanPar Industries Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary ShanPar Industries Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …
  • Japan Tobacco Inc (2914):製薬・医療:M&Aディール及び事業提携情報
    Summary Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes. It also manufactures, markets and sells varied pharmaceutical and processed food products such as frozen cooked rice and noodles, instant noodles, bread and frozen bread, mineral water, and seasoning, p …
  • Living Proof Inc-製薬・医療分野:企業M&A・提携分析
    Summary Living Proof Inc (Living Proof) is a healthcare products provider that offers hair care products. The company offers hair travel kits, dry shampoos, hair conditioner, styling treatment kits, night cap overnight perfector, pre shampoo treatment, timeless shampoo, plumping mousse, nourishing s …
  • Panasonic Corporation:企業の戦略・SWOT・財務分析
    Panasonic Corporation - Strategy, SWOT and Corporate Finance Report Summary Panasonic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Strike Energy Ltd (STX):石油・ガス:M&Aディール及び事業提携情報
    Summary Strike Energy Ltd (Strike Energy) is an oil and gas exploration and development company that explores, produces, and develops shale oil and gas. The company provides properties such as Eagle Ford Shale, Permian Basin, Cooper Basin, gulf coast conventional, and others. It has exploration and …
  • Intralot S.A. (INLOT):企業の財務・戦略的SWOT分析
    Intralot S.A. (INLOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • China Shineway Pharmaceutical Group Ltd (2877):企業の財務・戦略的SWOT分析
    Summary China Shineway Pharmaceutical Group Ltd (China Shineway) is a pharmaceutical company that offers development, manufacture and sales of Chinese medicines. The company’s products comprise shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft ca …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sabre Corporation (SABR):企業の財務・戦略的SWOT分析
    Sabre Corporation (SABR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Municipal Energy Agency of Nebraska:発電所・企業SWOT分析
    Municipal Energy Agency of Nebraska – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products such as lipovitan D, riup, clarith, z …
  • SRI International-医療機器分野:企業M&A・提携分析
    Summary SRI International (SRI) is a research institute which provides commercial research and development programs. It conducts research and development in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economi …
  • Balaji Amines Ltd (BALAMINES)
    Balaji Amines Ltd (BALAMINES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Sibanye Gold Ltd:企業の戦略・SWOT・財務情報
    Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • AXO Science SAS:企業の製品パイプライン分析2018
    Summary AXO Science SAS (AXO) is a developer of high output and multi-parametric analysis solutions for characterizing biological samples. The company offers solutions such as blood genotyping, allergy diagnosis, cancer diagnosis, pathogens detection, customized assays, sperm tracker, microarray spo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆